Bendazac sodium
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384624This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H13N2O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4SW243Q44Z, chemically known as sodium, ((1-(phenylmethyl)-1h-indazol-3-yl)oxy)acetate but more generally known as bendazac sodium, which bears US NIH Compound Identifier 31020. European Medicines Agency schedules Bendazac sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00698MIG. Most nations, for tariff and trade purposes, schedule bendazac sodium under HS 29339990. As of Q4 2014, BENDAZAC SODIUM remains US FDA's Preferred Term for this commodity. SMILES: C1CCC(CC1)CN2C3CCCCC3C(N2)OCC(=O)[O-].[NA+].
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.